Pancreas Transplantation.
- Author:
Duck Jong HAN
1
;
David ER SUTHERLAND
Author Information
1. Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. djhan@amc.seoul.kr
- Publication Type:Review
- Keywords:
Pancreas;
Transplantation;
Diabetes
- MeSH:
Cadaver;
Diabetes Complications;
Diabetes Mellitus;
Graft Survival;
Humans;
Illegitimacy;
Immunosuppressive Agents;
Insulin;
Living Donors;
Pancreas;
Pancreas Transplantation;
Postoperative Care;
Transplants
- From:Gut and Liver
2010;4(4):450-465
- CountryRepublic of Korea
- Language:English
-
Abstract:
Diabetes mellitus is generally treated with oral diabetic drugs and/or insulin. However, the morbidity and mortality associated with this condition increases over time, even in patients receiving intensive insulin treatment, and this is largely attributable to diabetic complications or the insulin therapy itself. Pancreas transplantation in humans was first conducted in 1966, since when there has been much debate regarding the legitimacy of this procedure. Technical refinements and the development of better immunosuppressants and better postoperative care have brought about marked improvements in patient and graft survival and a reduction in postoperative morbidity. Consequently, pancreas transplantation has become the curative treatment modality for diabetes, particularly for type I diabetes. An overview of pancreas transplantation is provided herein, covering the history of pancreas transplantation, indications for transplantation, cadaveric and living donors, surgical techniques, immunosuppressants, and outcome following pancreas transplantation. The impact of successful pancreas transplantation on the complications of diabetes will also be reviewed briefly.
